Brief: Lee's Pharmaceutical Posts QTRLY Profit Attributable Hk$39.9 Million
26/05/2020 11:23
May 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* LEE'S PHARMACEUTICAL- QTRLY PROFIT ATTRIBUTABLE HK$39.9
MILLION
VERSUS HK$47 MILLION
* LEE'S PHARMACEUTICAL - QTRLY REVENUE HK$273 MILLION, DOWN
3.5%
* LEE'S PHARMACEUTICAL- GROUP FORESEES CHALLENGING
ENVIRONMENT
WILL BE PERSISTED THROUGHOUT THIS YEAR
Source text for Eikon: ID:nHKS33xcVb
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals